NCT04593056View on ClinicalTrials.gov

Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

102,636

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

Warfarin

Warfarin dispensing claim is used as the reference

DRUG

Rivaroxaban

Rivaroxaban dispensing claim is used as the exposure

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04593056 - Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter